Merck KGaA is highlighted for having the highest average margin (81%) among companies involved in Trump's new drug program, suggesting it's a company to watch.
Source Post
I bought into $NVO after research the top companies by margin from trumps new government program website. E...
Feb 8, 2026
The creator discusses Donald Trump's new prescription drug program website, TrumpRx.gov, and highlights pharmaceutical companies involved, particularly Novo Nordisk (NVO), Eli Lilly (LLY), and Merck KGaA. The creator suggests these companies are poised to profit from the program and expresses a bullish sentiment towards them, especially NVO, which they previously recommended and saw a positive price movement.
Linked Mentions
Tickers discussed in this post
Eli Lilly (LLY) is mentioned as a key pharmaceutical company involved in Trump's new drug program, with good margins, suggesting a potential buy opportunity.
The creator is bullish on Novo Nordisk (NVO) due to its involvement in Trump's new prescription drug program and its strong margins, noting a recent price increase after their prior recommendation.
Linked Signals
Tracked calls opened from this post
NVObuy opened Feb 8, 2026
+5.63%